Ahead of Print

Invited Review

TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS
  • Abdulsamet Erden
Rheumatol Q 0; 0: 0-0 [e-Pub] DOI: 10.4274/qrheumatol.galenos.2023.76476
Abstract
AN OVERVIEW OF JANUS KINASE INHIBITORS
  • Fatih Albayrak
Rheumatol Q 0; 0: 0-0 [e-Pub] DOI: 10.4274/qrheumatol.galenos.2023.62207
Abstract
A REVIEW OF BARICITINIB: THE EFFICACY AND SAFETY IN RHEUMATIC DISEASES
  • Ayten Yazıcı
  • Senar Şan
Rheumatol Q 0; 0: 0-0 [e-Pub] DOI: 10.4274/qrheumatol.galenos.2023.80299
Abstract
UPADACITINIB IN ACTION: EFFICACY AND SAFETY IN THE TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS
  • Fatma Başıbüyük
  • İsmail Sarı
Rheumatol Q 0; 0: 0-0 [e-Pub] DOI: 10.4274/qrheumatol.galenos.2023.57966
Abstract
JAK INHIBITORS IN THE TREATMENT OF SYSTEMIC VASCULITIDES
  • Fatma Alibaz-Oner
Rheumatol Q 0; 0: 0-0 [e-Pub] DOI: 10.4274/qrheumatol.galenos.2023.29392
Abstract
JAK INHIBITORS IN SYSTEMIC SCLEROSIS: A SCOPING REVIEW
  • Fatma Başıbüyük
  • Merih Birlik
Rheumatol Q 0; 0: 0-0 [e-Pub] DOI: 10.4274/qrheumatol.galenos.2023.03511
Abstract
Advanced Search

About Journal

Forms

Useful Links

Subscribe
Latest Update: 29.09.2023
2023 © Galenos Publishing House.